AM-001 (AlphaMol)

N/A

Report date: 2025/06/23 17:27:15
NME

Base Information

Drug NameAM-001 (AlphaMol)
Drug Alias NameAM-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMRGPRX2 modulators
TargetsMRGPRX2
Therapy Area/IndicationsAutoimmune DiseasesUrticariaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAlphaMol Science Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlphaMol Science Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesUrticariaDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A